Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: One point from the filing...

"A takeover could not be accomplished because of the way PDS is owned and that is 50/50."

The above would be correct .... unless both companies agree ... right?

Would this be a correct statement, or am I way off base? :-)

Cherry

Share
New Message
Please login to post a reply